Details for Patent: 11,590,146
✉ Email this page to a colleague
Which drugs does patent 11,590,146 protect, and when does it expire?
Patent 11,590,146 protects KYZATREX and is included in one NDA.
This patent has twenty patent family members in eleven countries.
Drugs Protected by US Patent 11,590,146
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-001 | Jul 27, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-002 | Jul 27, 2022 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Marius Pharms Llc | KYZATREX | testosterone undecanoate | CAPSULE;ORAL | 213953-003 | Jul 27, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,590,146
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2822435 | ⤷ Try a Trial | |||
China | 105188670 | ⤷ Try a Trial | |||
European Patent Office | 2519230 | ⤷ Try a Trial | |||
European Patent Office | 2682111 | ⤷ Try a Trial | |||
European Patent Office | 2968137 | ⤷ Try a Trial | |||
Spain | 2710149 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |